ArticleBritish journal of cancer2019

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.

Jai-Hee Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.